Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Poljak

Showing results (231-240 of 350) with videos related to

Pageof 35
Sort By:
Eclinicalmedicine|October 20, 2022
HPV screening in the urine of transpeople - A prevalence studySophie Pils, Jana Mlakar, Mario Poljak, et al.
Intervirology|October 2, 2013
Impact of added fluvastatin to standard-of-care treatment on sustained virological response in naïve chronic hepatitis C Patients infected with genotypes 1 and 3Tanja Selic Kurincic, Gorazd Lesnicar, Mario Poljak, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|August 18, 2009
Digene HPV Genotyping RH Test RUO: comparative evaluation with INNO-LiPA HPV Genotyping Extra Test for detection of 18 high-risk and probable high-risk human papillomavirus genotypesKatja Seme, Snjezana Zidovec Lepej, Maja M Lunar, et al.
Vaccine|December 17, 2013
Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Central and Eastern EuropeMario Poljak, Katja Seme, Polona J Maver, et al.
Journal of Virological Methods|May 3, 2006
Evaluation of a commercial real-time PCR assay for quantitation of Epstein-Barr virus DNA in different groups of patientsSanja Kozić, Adriana Vince, Janja Iscić Bes, et al.
Virus Research|January 19, 2006
Prevalence of antiretroviral drug resistance mutations and HIV-1 non-B subtypes in newly diagnosed drug-naïve patients in Slovenia, 2000-2004Dunja Z Babic, Mojca Zelnikar, Katja Seme, et al.
International Journal of Cancer|September 28, 2018
DNA methylation markers as a triage test for identification of cervical lesions in a high risk human papillomavirus positive screening cohortRobert W van Leeuwen, Anja Oštrbenk, Mario Poljak, et al.
Advances in Anatomic Pathology|February 6, 2016
Laryngeal Squamous Intraepithelial Lesions: An Updated Review on Etiology, Classification, Molecular Changes, and TreatmentNina Gale, Douglas R Gnepp, Mario Poljak, et al.
AIDS Research and Human Retroviruses|August 22, 2012
The prevalence of transmitted drug resistance in newly diagnosed HIV-infected individuals in Croatia: the role of transmission clusters of men who have sex with men carrying the T215S surveillance drug resistance mutationIvana Grgic, Snjezana Zidovec Lepej, Maja M Lunar, et al.
Pathology, Research and Practice|August 29, 2021
Usefulness of high-risk human papillomavirus mRNA silver in situ hybridization diagnostic assay in oropharyngeal squamous cell carcinomasNina Gale, Mario Poljak, Metka Volavšek, et al.
Pageof 35

Showing results (231-240 of 350) with videos related to

Sort By:
Pageof 35
Eclinicalmedicine|October 20, 2022
HPV screening in the urine of transpeople - A prevalence studySophie Pils, Jana Mlakar, Mario Poljak, et al.
Intervirology|October 2, 2013
Impact of added fluvastatin to standard-of-care treatment on sustained virological response in naïve chronic hepatitis C Patients infected with genotypes 1 and 3Tanja Selic Kurincic, Gorazd Lesnicar, Mario Poljak, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|August 18, 2009
Digene HPV Genotyping RH Test RUO: comparative evaluation with INNO-LiPA HPV Genotyping Extra Test for detection of 18 high-risk and probable high-risk human papillomavirus genotypesKatja Seme, Snjezana Zidovec Lepej, Maja M Lunar, et al.
Vaccine|December 17, 2013
Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Central and Eastern EuropeMario Poljak, Katja Seme, Polona J Maver, et al.
Journal of Virological Methods|May 3, 2006
Evaluation of a commercial real-time PCR assay for quantitation of Epstein-Barr virus DNA in different groups of patientsSanja Kozić, Adriana Vince, Janja Iscić Bes, et al.
Virus Research|January 19, 2006
Prevalence of antiretroviral drug resistance mutations and HIV-1 non-B subtypes in newly diagnosed drug-naïve patients in Slovenia, 2000-2004Dunja Z Babic, Mojca Zelnikar, Katja Seme, et al.
International Journal of Cancer|September 28, 2018
DNA methylation markers as a triage test for identification of cervical lesions in a high risk human papillomavirus positive screening cohortRobert W van Leeuwen, Anja Oštrbenk, Mario Poljak, et al.
Advances in Anatomic Pathology|February 6, 2016
Laryngeal Squamous Intraepithelial Lesions: An Updated Review on Etiology, Classification, Molecular Changes, and TreatmentNina Gale, Douglas R Gnepp, Mario Poljak, et al.
AIDS Research and Human Retroviruses|August 22, 2012
The prevalence of transmitted drug resistance in newly diagnosed HIV-infected individuals in Croatia: the role of transmission clusters of men who have sex with men carrying the T215S surveillance drug resistance mutationIvana Grgic, Snjezana Zidovec Lepej, Maja M Lunar, et al.
Pathology, Research and Practice|August 29, 2021
Usefulness of high-risk human papillomavirus mRNA silver in situ hybridization diagnostic assay in oropharyngeal squamous cell carcinomasNina Gale, Mario Poljak, Metka Volavšek, et al.
Pageof 35